Cspc Pharmaceutical Group Stock Fundamentals
| CHJTF Stock | USD 0.54 0.00 0.00% |
CSPC Pharmaceutical Group fundamentals help investors to digest information that contributes to CSPC Pharmaceutical's financial success or failures. It also enables traders to predict the movement of CSPC Pink Sheet. The fundamental analysis module provides a way to measure CSPC Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSPC Pharmaceutical pink sheet.
CSPC |
CSPC Pharmaceutical Group Company Operating Margin Analysis
CSPC Pharmaceutical's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CSPC Pharmaceutical Operating Margin | 0.22 % |
Most of CSPC Pharmaceutical's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSPC Pharmaceutical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CSPC Pharmaceutical Group has an Operating Margin of 0.2214%. This is 100.63% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The operating margin for all United States stocks is 104.02% lower than that of the firm.
CSPC Pharmaceutical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSPC Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CSPC Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSPC Pharmaceutical competition to find correlations between indicators driving CSPC Pharmaceutical's intrinsic value. More Info.CSPC Pharmaceutical Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSPC Pharmaceutical Group is roughly 1.77 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSPC Pharmaceutical's earnings, one of the primary drivers of an investment's value.CSPC Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSPC Pharmaceutical's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CSPC Pharmaceutical could also be used in its relative valuation, which is a method of valuing CSPC Pharmaceutical by comparing valuation metrics of similar companies.CSPC Pharmaceutical is currently under evaluation in operating margin category among its peers.
CSPC Fundamentals
| Return On Equity | 0.2 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 11.19 B | |||
| Shares Outstanding | 11.93 B | |||
| Shares Owned By Insiders | 29.56 % | |||
| Shares Owned By Institutions | 34.01 % | |||
| Price To Earning | 14.83 X | |||
| Price To Book | 3.41 X | |||
| Price To Sales | 0.45 X | |||
| Revenue | 27.87 B | |||
| Gross Profit | 21.14 B | |||
| EBITDA | 7.72 B | |||
| Net Income | 5.61 B | |||
| Cash And Equivalents | 13.97 B | |||
| Cash Per Share | 1.17 X | |||
| Total Debt | 682.56 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 2.70 X | |||
| Book Value Per Share | 2.35 X | |||
| Cash Flow From Operations | 4.64 B | |||
| Earnings Per Share | 0.07 X | |||
| Price To Earnings To Growth | 2.55 X | |||
| Number Of Employees | 24.75 K | |||
| Beta | 0.76 | |||
| Market Capitalization | 13.6 B | |||
| Total Asset | 34.74 B | |||
| Z Score | 11.4 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 34.74 B | |||
| Last Dividend Paid | 0.24 |
About CSPC Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSPC Pharmaceutical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSPC Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSPC Pharmaceutical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Pink Sheet
CSPC Pharmaceutical financial ratios help investors to determine whether CSPC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Pharmaceutical security.